| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K66532283 |
| PharmacoGx | BRD-K66532283 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MNX1 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | CPSF4L | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | SH3GL2 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | MTHFS | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | DENND6A | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | BTN2A2 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | CEP170B | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | KIR2DL1 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | PNMAL2 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | PLEKHA8 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
